ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,375Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 96

$1.69M Total Retail Price of All Prescriptions

Rank: 5 out of 96

673 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 673 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 673 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 3,865 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$202 was the average price of a prescription from this provider, compared to $214 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
GABAPENTIN 615 314 1 1
HYDROCODONE-ACETAMINOPHEN 543 181 S3 2 5
DONEPEZIL HCL 427 386 3 4
CARBIDOPA-LEVODOPA 388 326 4 3
LEVETIRACETAM 278 109 5 2
CITALOPRAM HBR 244 174 6 30
TOPIRAMATE 229 45 7 6
CYMBALTA 224 84 8 13
TIZANIDINE HCL 196 22 9 10
NAMENDA 189 189 10 7
VENLAFAXINE HCL ER 164 68 11 45
LYRICA 163 64 12 9
PHENYTOIN SODIUM EXTENDED 153 44 13 16
OXYCODONE HCL-ACETAMINOPHEN 150 57 S2 14 37
TRAZODONE HCL 143 71 15 36
PRIMIDONE 130 99 16 12
SUMATRIPTAN SUCCINATE 125 12 17 28
BACLOFEN 119 0 18 11
AGGRENOX 117 84 19 52
METHADONE HCL 116 19 S2 20 40
FLUOXETINE HCL 103 47 21 51
TRAMADOL HCL 101 46 22 24
LAMOTRIGINE 97 11 23 8
OXYCONTIN 95 27 S2 24 42
ROPINIROLE HCL 93 76 25 22
ZOLPIDEM TARTRATE 89 39 26 19
ESCITALOPRAM OXALATE 88 44 27 53
CARBAMAZEPINE 85 19 28 17
MORPHINE SULFATE ER 84 30 S2 29 25
FENTANYL 83 51 S2 30 33
NORTRIPTYLINE HCL 83 18 30 27
CARISOPRODOL 71 0 R 32 34
DILANTIN 66 28 33 39
QUETIAPINE FUMARATE 65 35 34 59
SERTRALINE HCL 60 29 35 35
PROMETHAZINE HCL 58 11 R 36 44
MORPHINE SULFATE 54 22 S2 37 58
PLAVIX 51 47 38 49
EXELON 51 51 38 18
OMEPRAZOLE 50 22 40 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 24, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.